DANCR, an important cancer-related lncRNA (Thin et al., 2018), is known to promote cell growth in glioma and induce drug resistance through certain signaling pathways or sponging microRNAs (Ma et al., 2018; Xu et al., 2018; Feng et al., 2020). Here, DANCR is linked to central nervous system cancer.